Science

Sir Ravinder N. Maini, famous for the development of biological therapies, has been awarded Semmelweis Budapest Award in 2017 (VIDEO)

Sir Ravinder N. Maini, Professor Emeritus of Imperial College in London, Visiting Lecturer of Oxford University has been awarded Semmelweis Budapest Award in 2017. The scientist was awarded the most prestigious international scientific recognition of Semmelweis University for the development …

New gene affecting the development of a rare disease identified

A breakthrough has been made in a two-year research period by the identification of a gene responsible for the development of a rare neurological disease. Based on the paper published in EMBO Molecular Medicine Dr. Mária Judt Molnár, Director of the Department of …

Péter Ferdinandy and Pál Pacher are in the list of “Highly Cited Researchers”

The list entitled “ Highly Cited Researchers ” of 2017 prepared on the basis of the data provided by The Web Science has recently been released. This year 3300 researchers from 21 various scientific disciplines were recognized from all over the world, whose publications were the most frequently …

Opportunities in stem cell therapy for the developmental diseases of the enteric nervous system

The long term objective of the research laboratory of the Department of Anatomy, Hystology and Embryology lead by Dr. Nándor Nagy is the treatment of the developmental disorders of the enteric nervous system with stem cell therapy. Dr. Nándor Nagy …

NAP programme: A correlation between personality traits and migraine has been identified

People, who are more open to new experiences and are suffering from migraine, are less likely to suffer from depression as well. The latest finding of the MTA-SE-NAP B Genetic Brain Imaging Migraine Research Group also reveals that such people …

Semmelweis University becomes member of the largest European consortium of rheumatology

A large-scale European collaboration on the research of rheumatic diseases has been set up with the participation of Semmelweis University. The consortium Rheuma Tolerance for Cure (RTCure) is partially funded by the Horizon 2020 programme of the European Union and …

The first inpatient unit of rare diseases in Hungary opens at Semmelweis University

Hungary’s first inpatient unit of rare diseases was opened at Semmelweis University’s Department of Genomic Medicine and Rare Disorders. In her speech at the opening ceremony Dr. Mária Judit Molnár, director of the Department said that the university’s portfolio of …

World-class nanoScan SPECT-CT at Semmelweis University

A world-class nanoScan SPECT-CT will be procured by Semmelweis University with the use of a recently acquired fund. The project “The study of the endothelial impact and the in vivo distribution of nanoparticles with multimodal imaging systems” acquired a grant …

A new map drawn by Semmelweis researchers reveals links between the 250 most important diseases

An electronically available multimorbidity map has been made with the participation of Semmelweis University’s researchers. The map shows the comorbidity of various diseases and the links between the 250 most important illnesses. The open database, which was made with the …

1.5 billion-forint grant for tumour therapy device

The tender “Improving the efficiency of the electromagnetic tumour therapy device and the preparation for its integration into commercial use” lead by Semmelweis University received a grant of 1.472 billion forints as part of the Hungarian Competitiveness and Excellence Programme …

Page 1 of 1012345...10...Last »